Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus-16 Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04762225
What this trial is testing

RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanomaCervical Cancer
Repertoire Immune Medicines 7
Early research (Phase 1)Active Not RecruitingNCT05973487
What this trial is testing

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more
TScan Therapeutics, Inc. 840
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870
What this trial is testing

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Who this might be right for
Human Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Chicago 35
Testing effectiveness (Phase 2)UnknownNCT04800978
What this trial is testing

Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy

Who this might be right for
Cervical Cancer
Samsung Medical Center 37
Not applicableActive Not RecruitingNCT05812027
What this trial is testing

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerCervical CancerNon Small Cell Lung Cancer+4 more
TScan Therapeutics, Inc. 1,150
Testing effectiveness (Phase 2)Study completedNCT02426892
What this trial is testing

Nivolumab and HPV-16 Vaccination in Patients With HPV-16 Positive Incurable Solid Tumors

Who this might be right for
Solid Tumors
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)WithdrawnNCT04536922
What this trial is testing

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab

Who this might be right for
Metastatic HPV-16 Positive Squamous Cell Anal Cancer
National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07714577
What this trial is testing

Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection

Who this might be right for
HPV16/18 Positive
Tianjin First Central Hospital 200
Early research (Phase 1)UnknownNCT05895370
What this trial is testing

HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
BGI, China 12
Testing effectiveness (Phase 2)Study completedNCT03603808
What this trial is testing

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Who this might be right for
Anal Intraepithelial NeoplasiaHigh Grade Squamous Intraepithelial NeoplasiaHIV Positivity+2 more
AIDS Malignancy Consortium 44
Testing effectiveness (Phase 2)Study completedNCT04405349
What this trial is testing

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

Who this might be right for
Cervical CancerCervix Cancer
Nykode Therapeutics ASA 52
Testing effectiveness (Phase 2)Study completedNCT04646005
What this trial is testing

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Who this might be right for
Cervical Cancer
Regeneron Pharmaceuticals 113
Testing effectiveness (Phase 2)Study completedNCT04180215
What this trial is testing

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Hookipa Biotech GmbH 198
Testing effectiveness (Phase 2)Looking for participantsNCT05686226
What this trial is testing

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Who this might be right for
Cervical CancerThroat CancerOropharynx Cancer+18 more
Christian Hinrichs 20
Post-approval studies (Phase 4)Looking for participantsNCT05334706
What this trial is testing

Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

Who this might be right for
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)Human Papillomavirus (HPV) InfectionsHigh-risk HPV+1 more
Miquel Angel Pavon Ribas 69
Early research (Phase 1)Study completedNCT02821494
What this trial is testing

Hespecta Vaccination in HPV+ Tumors or Malignant Lesions

Who this might be right for
Tumors or Premalignant Lesions
Leiden University 25
Early research (Phase 1)Looking for participantsNCT07081984
What this trial is testing

Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors

Who this might be right for
HPV 16+ Recurrent or Metastatic CancerHNSCCCervical Cancer
Therorna 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07628062
What this trial is testing

Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation

Who this might be right for
HPV-Positive Oropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaHead and Neck Cancer
ImmunityBio, Inc. 70
Testing effectiveness (Phase 2)Ended earlyNCT03258008
What this trial is testing

Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer

Who this might be right for
Malignant Neoplasms of Ill-defined Secondary and Unspecified SitesMalignant Neoplasms of Lip Oral Cavity and PharynxOropharyngeal Cancer
M.D. Anderson Cancer Center 3
Very early researchActive Not RecruitingNCT06373380
What this trial is testing

HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

Who this might be right for
HPV16+ Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 7
Next Page